Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BE CAREFUL - Just saw this news article. MIGHT be rough sledding tomorrow.
Sixty-one cases of myocarditis, pericarditis, or both following a Novavax vaccination were reported in the World Health Organization’s vaccine safety database through Aug. 23, 2022, Spanish researchers found.
Using pre-pandemic rates of heart inflammation in the population, the researchers calculated that the number of post-vaccination cases was higher than expected.
Reporting odds ratio values of higher than one indicate a higher-than-expected rate. For myocarditis following Novavax vaccination, the ratio was 5.2. For pericarditis, it was 24.75. For myopericarditis, or both conditions at once, it was 14.4.
Heart inflammation is a known side effect of the Pfizer and Moderna COVID-19 vaccines, which utilize messenger RNA (mRNA) technology, but little data has been collected on the condition following Novavax vaccination, which does not contain mRNA.
Novavax COVID-19 Vaccine Associated with Heart Inflammation: Study
NVAX
Novavax Inc
11.27
-0.74 (-6.16%)
Volume: 6,466,637
Day Range: 11.18 - 12.2799
Bid: 11.23
Ask: 11.29
Last Trade Time: 7:59:58 PM EST
Total Trades: 49,307
FDA_briefing_document_for VRBPAC advisory_committee—>bullish for PFE/MRNA/NVAX:
https://www.fda.gov/media/164699/download (p.5; p.18)
NVAX gets great news and runs almost to $13 on Monday. Last Friday's action gave a clue on news coming.
That did not take long. More fun to come as we set in under $10.
mb
NVAX getting closer to $13s.
Just waiting for the sudden breakaway in January which will alarm the shorts.
mb
yes, NVAX
Novavax Inc
11.685
0.355 (3.13%)
Volume: 4,905,686
Day Range: 10.57 - 11.805
Bid: 11.68
Ask: 11.69
Last Trade Time: 1:23:53 PM EST
Total Trades: 36,021
Mick-
NVAX will eventually be trading in the upper teens. The company now has a sudden global appeal.
Lots of cash flowing into NVAX now.
mb
RETREADED FROM OVER $75 2022 $NVAX
through 2022 $NVAX
http://www.stockta.com/cgi-bin/analysis.pl?symb=NVAX
https://www.stockscores.com/charts/charts/?ticker=NVAX
https://seekingalpha.com/symbol/NVAX
https://www.otcmarkets.com/stock/NVAX
https://stockcharts.com/h-sc/ui
https://stockcharts.com/c-sc/sc?s=NVAX&p=D&b=5&g=0&i=t0176762015c&r=1671227019029
NVAX
Novavax Inc
9.9412
-0.3388 (-3.30%)
Volume: 2,642,538
Day Range: 9.89 - 11.12
Bid: 9.94
Ask: 9.95
Last Trade Time: 10:31:12 AM EST
Total Trades: 15,930
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates 12/30/2022 08:00:00 AM
yes, dis started wit covid @ under $7 wow returning to under $10
$NVAX reloaded the sub $10 pullback when market tanked.
With increasing china virus infections.
Nvax should be able to get billion dosea aupply to china with help of Serum Institutes of india.
We will see
NVAX
Novavax Inc
11.00
-0.32 (-2.83%)
Volume: 38,702,375
Day Range: 9.36 - 11.16
Last Trade Time: 8:00:00 PM EST
Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a Booster
Just wish there were more options (LOCATIONS!) for receiving Novavax vaccines!
As of today correct but when I posted that it looked ready to breakout
Starting to move.
The analyst’s rating stays a Buy, while his $126 price target suggests investors could be sitting on returns of 314% in a year’s time.
Can’t wait
NVAX
Novavax Inc
32.87
-2.35 (-6.67%)
Volume: 4,572,181
Day Range: 32.61 - 36.165
Bid: 32.76
Ask: 32.95
Last Trade Time: 6:45:27 PM EDT
Total Trades: 52,449
NVAX Detailed Quote
Novavax to Participate in Fireside Chat at the SVB Securities Virtual Vaccine Forum.
https://ih.advfn.com/stock-market/NASDAQ/novavax-NVAX/stock-news/88819100/novavax-to-participate-in-fireside-chat-at-the-svb
$NVAX and Serum Institute of India to develop #monkeypox vaccine: https://www.businesstoday.in/latest/trends/story/indian-pharma-cos-to-develop-monkeypox-vaccines-drugs-and-testing-kits-342813-2022-07-26
“U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older”
OK…now do NanoFlu™?!
I want to see this-> ‘U.S. CDC Advisory Committee Unanimously Recommends Novavax NanoFlu™? Vaccine, Adjuvanted as THE preferred seasonal influenza vaccine.’
C’mon! It has already bested Fluzone®? High-Dose in a challenge trial.
NVAX
Novavax Inc
54.22
2.60 (5.04%)
Volume: 13,721,813
Day Range: 47.6783 - 54.83
Bid: 54.05
Ask: 54.30
Last Trade Time: 7:59:56 PM EDT
Total Trades: 129,545
NVAX Detailed Quote
Lol down 20% and not a peep. Another Garbage Fake Vaccine just like all the rest.
Just out;
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.
Im sure kicking myself 4 weeks ago but here we are now and expecting 100$ is just a quick flip away
I don't buy the calls, extremely illiquid on these.
Sup homie calls here been mega $$$$$$ and agree a lot more coming..
Must be a good reason for the sp to drop that much
Fantastic move these past couple of weeks, definitely more to come, a lot more.
Yeppers, no doubt... Monster day
A couple of days like today and we’ll be there pretty fast
Heading towards $100
They’d be negligent not to.
Followers
|
341
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
8595
|
Created
|
06/19/03
|
Type
|
Free
|
Moderators mick JoeForkeyBolo |
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases.
Using innovative proprietary recombinant nanoparticle vaccine technology,
we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...
INVESTORS
Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease. More...
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |